Tweedy Browne Co. Bristol Myers Squibb CO Transaction History
Tweedy, Browne CO LLC
- $1.11 Billion
- Q3 2025
A detailed history of Tweedy Browne Co. (Tweedy, Browne CO LLC) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tweedy, Browne CO LLC holds 14,466 shares of BMY stock, worth $677,153. This represents 0.06% of its overall portfolio holdings.
Number of Shares
14,466
Previous 7,184
101.36%
Holding current value
$677,153
Previous $332,000
96.39%
% of portfolio
0.06%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...